The role of calnexin in NK-target cell interaction.
In this study, a relationship between target cell sensitivity to natural killing and target cell expression of the molecular chaperone++ calnexin was assessed. The NK-resistant cell line NKR was originally derived from the NK-sensitive, human T-cell line CEM and does not synthesize calnexin protein or mRNA. The cell lines CEM, NKR and 1B9 (NKR transfected with a calnexin cDNA) were compared in a number of assays. All the lines but CEM were resistant to NK in conventional 4 h cytotoxicity assay, but were highly sensitive to IL-2 activated NK. Incubation of NK cells with CEM but not with the other two lines led to increased expression of the NK cell activation marker CD69. Treatment of effector cells with PGE2 and TGF-beta resulted in an inhibition of NK activity and CD69 expression. The calnexin transfected clone 1B9 clone had intermediate ability to block cytotoxicity in cold target inhibition assay compared to CEM and NKR. Expression of the adhesion molecules CD44 and LFA-1alpha was significantly higher on both calnexin positive cell lines compared to NKR. These data suggest that calnexin controls the expression of some, but not all, target structures that are necessary for binding and activation of NK cells.
Malyguine
A M
AM
Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.
Scott
J E
JE
Dawson
J R
JR
D018845:CD11 Antigens / Q000032:analysis; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000502:physiology*; D037281:Calnexin; D002450:Cell Communication / Q000502:physiology; D003601:Cytotoxicity Tests, Immunologic; D018076:DNA, Complementary / Q000235:genetics; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis; D007694:Killer Cells, Natural / Q000166:cytology* / Q000502:physiology*; D018832:Molecular Chaperones / Q000502:physiology; D014162:Transfection / Q000235:genetics; D014407:Tumor Cells, Cultured / Q000166:cytology / Q000502:physiology
D018845:CD11 Antigens; D002135:Calcium-Binding Proteins; D018076:DNA, Complementary; D018960:Hyaluronan Receptors; D018832:Molecular Chaperones; D037281:Calnexin